Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationGastroenterology 2010, 138(7): 2246-59
AbstractIdiosyncratic drug-induced liver injury (DILI) is a rare disorder that is not related directly to dosage and little is known about individuals who are at increased risk. There are no suitable preclinical models for the study of idiosyncratic DILI and its pathogenesis is poorly understood. It is likely to arise from complex interactions among genetic, nongenetic host susceptibility, and environmental factors. Nongenetic risk factors include age, sex, and other diseases (eg, chronic liver disease or human immunodeficiency virus infection). Compound-specific risk factors include daily dose, metabolism characteristics, and propensity for drug interactions. Alcohol consumption has been proposed as a risk factor for DILI from medications, but there is insufficient evidence to support this. Many studies have explored genetic defects that might be involved in pathogenesis and focused on genes involved in drug metabolism and the immune response. Multicenter databases of patients with DILI (the United States Drug Induced Liver Injury Network, DILIGEN, and the Spanish DILI registry) are important tools for clinical and genetic research. A genome-wide association study of flucloxacillin hepatotoxicity has yielded groundbreaking results and many similar studies are underway. Nonetheless, DILI is challenging to investigate because of its rarity, the lack of experimental models, the number of medications that might cause it, and challenges to diagnosis.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Epidemiology of idiosyncratic drug-induced liver injury.
- Authors: Bell LN, Chalasani N
- Issue date: 2009 Nov
- Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.
- Authors: Fontana RJ
- Issue date: 2014 Apr
- Current challenges and controversies in drug-induced liver injury.
- Authors: Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M
- Issue date: 2012 Dec 1
- Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
- Authors: Lammert C, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N
- Issue date: 2008 Jun
- Drug-induced liver injury.
- Authors: Leise MD, Poterucha JJ, Talwalkar JA
- Issue date: 2014 Jan